Top 30 Centers of Excellence 2026

This report forms part of The Economy Rankings Healthcare Ranking series, which evaluates hospitals, medical institutions, pharmaceutical organizations, medical technology companies, and healthcare systems across global healthcare markets.

Centers of Excellence have become one of the most important organizational models in advanced healthcare. Rather than representing a single hospital type, a Center of Excellence refers to a concentrated clinical platform that combines specialist expertise, multidisciplinary care, clinical governance, research activity, patient pathway design, and measurable institutional depth around a defined disease area, procedure category, or complex care need.

In modern healthcare systems, Centers of Excellence are increasingly used to manage high-cost, high-risk, or highly specialized conditions such as cancer, cardiovascular disease, transplantation, rare diseases, pediatric complex care, spine surgery, orthopedics, ophthalmology, neurology, and advanced diagnostics. Their importance lies not only in clinical capability, but also in their ability to standardize care pathways, reduce fragmentation, support research translation, and improve access to expert decision-making.

The Center of Excellence model is especially relevant for employers, insurers, governments, and international patients seeking trusted providers for complex cases. Institutions such as Mayo Clinic market customizable Center of Excellence programs for complex conditions including cancer, spine surgery, transplant, and other serious illnesses, reflecting how the model has moved from internal clinical organization into healthcare purchasing and referral strategy.

This ranking identifies healthcare institutions and specialist programs whose Centers of Excellence demonstrate sustained relevance across clinical specialization, multidisciplinary integration, research capability, referral influence, and institutional reputation. Rather than ranking individual physicians or isolated departments, the objective is to recognize institutional platforms that function as durable reference centers within advanced healthcare.

Market Overview

The Center of Excellence sector continues to expand as healthcare systems face rising complexity in diagnosis, treatment selection, care coordination, and cost management. Patients with advanced, rare, chronic, or high-risk conditions increasingly require integrated clinical teams rather than isolated specialist encounters. Centers of Excellence respond to this need by organizing care around disease pathways and patient journeys instead of traditional departmental silos.

In the United States, Centers of Excellence are increasingly used by employers, health plans, and provider networks to direct complex cases toward institutions with recognized expertise. These programs often focus on high-cost areas such as oncology, cardiovascular care, spine surgery, joint replacement, transplantation, fertility, bariatric surgery, and rare diseases. The goal is to improve appropriateness of care, reduce avoidable variation, and provide access to experienced multidisciplinary teams.

In Europe and Asia, the Center of Excellence model is often embedded within university hospitals, national referral centers, specialist institutes, and public-private healthcare networks. Institutions such as Charité, Karolinska, Moorfields, Great Ormond Street Hospital, Sheba Medical Center, and National Cancer Center Hospital Japan demonstrate how specialist concentration can support research, education, and advanced patient care across national healthcare systems.

The model is also increasingly important for healthcare globalization. International patients, regional insurers, and medical travel facilitators often look for institutions with recognized Centers of Excellence because such designations provide a practical signal of capability, focus, and institutional maturity. Cancer centers, heart centers, eye hospitals, pediatric hospitals, orthopedic institutes, and transplant centers are especially prominent within cross-border healthcare.

At the same time, the Center of Excellence label is not uniformly regulated across markets. Some institutions use the term formally, while others operate equivalent specialist platforms under institute, center, department, or program names. For this reason, this ranking evaluates the structural substance of the platform rather than relying only on whether an organization explicitly uses the phrase “Center of Excellence.”

Industry Trend — 2026

The Center of Excellence industry in 2026 is shaped by the growing need for precision, coordination, and specialization in healthcare delivery. As treatment options become more complex, institutions that can combine clinical expertise, diagnostic depth, research infrastructure, and multidisciplinary care coordination are increasingly important.

Precision medicine is one of the strongest drivers of Center of Excellence development. Oncology, rare disease, cardiovascular genetics, immunology, neurology, and transplant medicine increasingly require genomic testing, molecular diagnostics, specialized imaging, and tailored treatment pathways. Centers of Excellence are well positioned to manage these workflows because they can concentrate expertise, technology, and data infrastructure within defined clinical programs.

Employer and payer adoption is another defining trend. Large employers and insurers are increasingly interested in directing complex cases to high-performing specialty networks. Mayo Clinic’s Complex Care Program is an example of this model, positioning Center of Excellence access around high-cost, high-risk conditions where expert review and coordinated treatment planning may materially affect outcomes and cost.

Digital care coordination is also changing the sector. Leading Centers of Excellence are investing in virtual second opinions, remote case review, digital intake, longitudinal monitoring, clinical registries, AI-supported diagnostics, and patient navigation. These systems allow specialist institutions to extend their expertise beyond local catchment areas.

Research integration remains central. Centers of Excellence with strong clinical trial infrastructure can offer patients access to investigational therapies, new devices, advanced procedures, and novel care pathways. In oncology, cardiology, orthopedics, ophthalmology, pediatrics, and rare diseases, this research capability increasingly differentiates leading centers from standard specialist providers.

As healthcare systems continue to prioritize quality, efficiency, and specialization, institutions with mature Centers of Excellence are likely to gain further influence within referral networks, employer healthcare programs, medical travel markets, and academic healthcare systems.

Methodology — Core Eligibility Criteria

To ensure structural consistency within the category, institutions and programs considered for this ranking were evaluated based on the following eligibility conditions:

• Operates as a recognized Center of Excellence, specialist institute, disease-focused center, or equivalent advanced clinical program
• Provides concentrated expertise in one or more areas such as oncology, cardiovascular care, orthopedics, pediatrics, transplantation, ophthalmology, neurology, rare diseases, or complex care
• Maintains a multidisciplinary care model involving specialist physicians, surgeons, nurses, diagnostics, rehabilitation, research, and patient navigation
• Demonstrates institutional relevance through referral activity, research output, clinical trial participation, education, or international reputation
• Maintains governance systems supporting clinical quality, patient safety, care pathway design, and specialist outcome monitoring

General hospitals without a clearly identifiable specialist platform, purely commercial clinics without advanced multidisciplinary infrastructure, and organizations whose primary function is non-clinical research were generally excluded.

Methodology — Ranking Factors

Institutions included in the ranking were evaluated using a combination of qualitative and structural considerations rather than short-term performance metrics. Key factors considered include:

• Strength and clarity of the Center of Excellence model
• Depth of clinical specialization and multidisciplinary integration
• Reputation among physicians, patients, payers, researchers, and healthcare systems
• Research productivity, clinical trial access, and translational medicine capability
• Role in complex case management, second opinions, or high-risk treatment pathways
• Breadth of supporting diagnostics, surgery, rehabilitation, and follow-up services
• International referral influence and institutional brand credibility
• Governance stability, academic integration, and long-term platform resilience

The objective of the ranking is to identify Centers of Excellence whose specialist platforms maintain sustained relevance within the global healthcare ecosystem.

The Healthcare Ranking Top 30 Centers of Excellence 2026 ranking evaluates institutions and specialist programs that serve as reference platforms for complex, high-risk, or highly specialized healthcare needs.

The ranking universe consisted of approximately 110 Centers of Excellence and equivalent specialist programs globally, from which 30 institutions were selected for inclusion.

Tier classifications reflect relative institutional positioning within the Center of Excellence segment and do not represent clinical outcome rankings, patient recommendations, or investment recommendations.

---

Company Profiles and Further Reference

Organization names appearing in this ranking are linked to their corresponding profiles in The Economy Wiki for companies. These profiles provide additional background on each institution, including its principal activities, clinical or commercial focus, market positioning, leadership, corporate information, related rankings, and analysis across The Economy Network.

The Economy Wiki profiles are maintained as editorial reference pages and may be updated as new public information becomes available. A linked profile does not affect ranking eligibility or tier classification.

---

Tier I — Leading Centers of Excellence

Mayo Clinic Complex Care Program

• Headquarters: Rochester, United States
• Founded: 1864

Mayo Clinic Complex Care Program represents one of the clearest institutional examples of the Center of Excellence model applied to complex, high-cost, and high-risk healthcare needs. The program is designed to help covered populations access Mayo Clinic expertise for serious and complex conditions, including cancer, spine surgery, transplantation, and other difficult medical cases.

The strength of Mayo Clinic’s model lies in its integrated multispecialty structure. Rather than approaching complex conditions through isolated departments, Mayo Clinic coordinates care through physician-led teams, advanced diagnostics, specialty consultations, and treatment planning across multiple disciplines. This makes the institution especially relevant for cases where diagnosis is uncertain, treatment options are complex, or multidisciplinary evaluation is required.

Mayo Clinic’s broader academic and educational infrastructure reinforces its Center of Excellence profile. Mayo Clinic College of Medicine and Science offers extensive medical, surgical, health sciences, and biomedical research training programs across multiple locations, supporting the institution’s role in clinical education and professional development.

Its combination of clinical reputation, multispecialty integration, complex case capability, employer-facing Center of Excellence design, and research-backed care delivery supports its position as a leading Center of Excellence platform in 2026.

Cleveland Clinic Cardiac Center of Excellence

• Headquarters: Cleveland, United States
• Founded: 1921

Cleveland Clinic Cardiac Center of Excellence is one of the most prominent examples of a focused specialty platform built around cardiovascular medicine. Cleveland Clinic describes its Cardiac Center of Excellence as a program delivering expert cardiac care through innovative procedures and specialist care, while the broader institution organizes related specialties through integrated institutes.

The program benefits from Cleveland Clinic’s long-standing cardiovascular reputation and its institute-based care model. By organizing related clinical disciplines around disease areas and patient needs, the institution supports multidisciplinary evaluation, procedural depth, surgical expertise, imaging, rehabilitation, and longitudinal follow-up.

Cleveland Clinic’s Center of Excellence relevance extends beyond cardiology alone. Its broader healthcare platform includes advanced specialty institutes, regional hospitals, surgical capacity, research services, and international locations. This gives the cardiac program access to institutional infrastructure that supports complex case management and innovation.

The strength of the Cleveland Clinic model lies in its ability to combine specialty concentration with operational scale. For cardiovascular disease, where diagnostic precision, procedural volume, surgical experience, and post-procedure management are critical, the institution’s integrated model remains highly influential.

Its focused cardiac expertise, global recognition, institute-based organization, and employer-facing Center of Excellence structure support its position among leading global Centers of Excellence.

MD Anderson Cancer Center

• Headquarters: Houston, United States
• Founded: 1941

The University of Texas MD Anderson Cancer Center is one of the world’s most important oncology Centers of Excellence. Created in 1941 as part of The University of Texas System, MD Anderson became one of the original three comprehensive cancer centers designated under the U.S. National Cancer Act of 1971.

MD Anderson’s Center of Excellence profile is rooted in its full institutional focus on cancer. The center combines medical oncology, surgical oncology, radiation oncology, pathology, imaging, immunotherapy, genomics, prevention, clinical trials, and survivorship care within a disease-focused platform. This depth allows it to manage both common and rare cancers through specialized teams and research-driven treatment pathways.

The institution’s national and international reputation reinforces its role as a referral center for complex oncology cases. MD Anderson announced that it was ranked No. 1 in the United States for cancer care in the 2025–2026 U.S. News & World Report Best Hospitals survey, reflecting continued recognition of its oncology platform.

MD Anderson’s combination of comprehensive cancer specialization, clinical trial infrastructure, translational research, multidisciplinary care, and global reputation supports its position as one of the leading Centers of Excellence in healthcare.

Boston Children’s Hospital

• Headquarters: Boston, United States
• Founded: 1869

Boston Children’s Hospital is a leading pediatric Center of Excellence, combining complex pediatric care, research, education, and subspecialty medicine. The institution describes its mission around caring for children of all ages and conditions, from rare diseases to common injuries, while advancing pediatric research and specialist care.

The hospital’s Center of Excellence profile is built around pediatric complexity. Children with rare diseases, congenital conditions, complex cardiac disease, neurological disorders, cancer, transplant needs, genetic syndromes, and intensive care requirements often require coordinated teams that integrate multiple specialties. Boston Children’s has developed one of the most comprehensive pediatric platforms for this kind of care.

Its location in Boston’s Longwood Medical and Academic Area and its academic relationship with Harvard Medical School reinforce its research and teaching capabilities. The institution’s pediatric specialization allows it to concentrate expertise, technology, and family-centered care processes around children and adolescents rather than adapting adult care models.

Boston Children’s strength lies in its combination of pediatric breadth and subspecialty depth. As pediatric medicine becomes more genomic, technologically intensive, and multidisciplinary, the institution remains one of the world’s most influential Centers of Excellence for children’s health.

Hospital for Special Surgery

• Headquarters: New York, United States
• Founded: 1863

Hospital for Special Surgery is a leading musculoskeletal Center of Excellence focused on orthopedics, rheumatology, rehabilitation, sports medicine, and complex joint and spine care. Its highly specialized model makes it a reference institution for patients requiring advanced musculoskeletal evaluation, surgery, and recovery pathways.

The institution’s Center of Excellence strength lies in its concentrated clinical identity. Rather than functioning as a broad general hospital, HSS focuses institutional resources around musculoskeletal medicine. This creates depth across joint replacement, spine surgery, sports medicine, pediatric orthopedics, hand surgery, foot and ankle care, trauma-related conditions, rheumatology, and rehabilitation.

HSS’s model is especially relevant to the Center of Excellence category because musculoskeletal care often benefits from high procedural experience, specialist teams, standardized pathways, imaging support, rehabilitation integration, and outcome monitoring. These characteristics align closely with the core logic of the Center of Excellence model.

Its long-standing reputation, specialty focus, academic affiliations, surgical expertise, and international patient recognition support its position among the leading Centers of Excellence globally.

---

Tier II — Established Centers of Excellence

(Alphabetical order)

Charité Center for Rare Diseases

• Headquarters: Berlin, Germany
• Founded: 1710

Charité Center for Rare Diseases represents the Center of Excellence model within one of Europe’s most important university medicine systems. Rare disease care requires multidisciplinary evaluation, advanced diagnostics, genetics, long-term care coordination, and access to research networks, making it particularly suited to a specialist center structure.

Charité’s broader academic platform provides the clinical and scientific environment needed for rare disease work. The institution combines university hospitals, medical faculty, research infrastructure, and specialist departments across Berlin, supporting complex diagnostic and therapeutic pathways.

The center’s relevance lies in its ability to concentrate expertise for patients whose conditions may not fit standard specialty boundaries. In rare diseases, delayed diagnosis and fragmented care are common challenges. A dedicated rare disease center can help coordinate specialist review, molecular testing, family counseling, and research access.

Charité’s academic depth, European influence, and disease-focused coordination support its position among established Centers of Excellence.

Dana-Farber Brigham Cancer Center

• Headquarters: Boston, United States
• Founded: 1947

Dana-Farber Brigham Cancer Center is a major oncology Center of Excellence combining the cancer expertise of Dana-Farber Cancer Institute with the clinical and hospital infrastructure of Mass General Brigham. The platform provides specialized cancer care across medical oncology, surgical oncology, radiation oncology, hematologic malignancies, immunotherapy, precision medicine, and clinical trials.

Its strength lies in the integration of academic research and advanced clinical care. Cancer care increasingly depends on molecular diagnostics, targeted therapies, cell therapy, multidisciplinary tumor boards, and access to investigational treatments. Dana-Farber Brigham’s model is structured around these complex oncology needs.

The institution’s Boston location places it within one of the world’s strongest biomedical ecosystems, with access to universities, research institutes, biotechnology companies, and clinical trial networks. This environment reinforces its Center of Excellence profile.

Dana-Farber Brigham’s focused oncology identity, research depth, academic affiliations, and specialist clinical platform support its inclusion among established Centers of Excellence.

Great Ormond Street Hospital Rare Disease and Pediatric Complex Care Platform

• Headquarters: London, United Kingdom
• Founded: 1852

Great Ormond Street Hospital is one of the world’s most recognized pediatric specialist institutions and functions as a Center of Excellence for children with rare, complex, and highly specialized medical needs. The hospital provides care across pediatric cardiology, neurology, immunology, genetics, oncology, surgery, intensive care, and congenital conditions.

Its Center of Excellence profile is particularly strong in rare and complex pediatric disease. Children requiring highly specialized care often need coordinated teams involving physicians, surgeons, geneticists, nurses, therapists, researchers, and family support services. GOSH’s institutional model is built around this type of multidisciplinary pediatric care.

The hospital’s relationship with University College London and its research infrastructure reinforce its role in pediatric innovation. It serves as both a national referral center and an international reference institution for complex childhood disease.

Great Ormond Street Hospital’s pediatric specialization, research integration, rare disease expertise, and global reputation support its position among established Centers of Excellence.

Johns Hopkins Comprehensive Transplant Center

• Headquarters: Baltimore, United States
• Founded: 1889

Johns Hopkins Comprehensive Transplant Center is a major Center of Excellence focused on organ transplantation and complex surgical care. Transplant medicine is one of the clearest examples of a field requiring a highly coordinated multidisciplinary platform, involving surgery, immunology, hepatology, nephrology, cardiology, pulmonology, infectious disease, pathology, intensive care, pharmacy, nursing, and long-term follow-up.

The center benefits from Johns Hopkins Medicine’s broader academic environment, including its medical school, hospital system, research infrastructure, and history of clinical innovation. Transplant programs require not only surgical expertise but also advanced patient selection, donor management, immunosuppression protocols, complication management, and lifelong care coordination.

Johns Hopkins’ institutional reputation and academic depth support the transplant center’s role as a reference platform for complex cases. Its model reflects how Centers of Excellence can organize care around high-risk procedures where experience, coordination, and clinical judgment are essential.

The center’s specialty depth, academic integration, and complex care capability support its inclusion among established Centers of Excellence.

Mass General Brigham Cancer Institute

• Headquarters: Boston, United States
• Founded: 1994

Mass General Brigham Cancer Institute represents a major academic oncology Center of Excellence within one of the world’s most prominent healthcare systems. The institute brings together cancer care, research, and clinical expertise across Mass General Brigham’s network, including Massachusetts General Hospital and Brigham and Women’s Hospital.

The platform’s strength lies in its ability to coordinate oncology care across major Harvard-affiliated teaching hospitals, specialty clinics, research laboratories, and clinical trial programs. It supports cancer treatment across medical oncology, surgical oncology, radiation oncology, hematology, imaging, pathology, genomics, and survivorship.

As oncology becomes more specialized and data-intensive, integrated cancer institutes are increasingly important. They allow institutions to standardize care pathways, expand clinical trial access, coordinate multidisciplinary treatment, and translate research discoveries into patient care.

Mass General Brigham Cancer Institute’s academic prestige, clinical scale, research infrastructure, and Boston biomedical ecosystem support its role as an established Center of Excellence.

Memorial Sloan Kettering Cancer Center

• Headquarters: New York, United States
• Founded: 1884

Memorial Sloan Kettering Cancer Center is one of the world’s most established cancer Centers of Excellence. Its full institutional focus on cancer allows it to concentrate clinical expertise, research, diagnostics, surgery, radiation therapy, immunology, molecular oncology, and supportive care around a single disease domain.

MSK’s Center of Excellence profile is supported by its disease-specific programs, clinical trial infrastructure, Sloan Kettering Institute research base, and long-standing oncology reputation. The institution is particularly important in cancer surgery, hematologic malignancies, immunotherapy, targeted therapy, molecular diagnostics, and rare tumor care.

The center’s location in New York and its global referral profile reinforce its international influence. Patients, physicians, researchers, and industry partners recognize MSK as a major platform for advanced oncology treatment and research translation.

Its specialist identity, research productivity, multidisciplinary care model, and institutional longevity support its inclusion among established Centers of Excellence.

Moorfields Eye Hospital and UCL Institute of Ophthalmology

• Headquarters: London, United Kingdom
• Founded: 1805

Moorfields Eye Hospital, together with the UCL Institute of Ophthalmology, forms one of the world’s leading ophthalmology Centers of Excellence. The institution traces its history to 1805 and has long been associated with specialist eye care, ophthalmic training, and vision research.

Ophthalmology is particularly well suited to the Center of Excellence model because it relies on specialist diagnostics, imaging, microsurgery, retinal therapies, corneal care, glaucoma management, pediatric ophthalmology, ocular genetics, and long-term disease monitoring. Moorfields concentrates these capabilities within a dedicated eye care platform.

The connection with UCL Institute of Ophthalmology strengthens its research and academic profile. This allows the institution to participate in translational work involving retinal disease, gene therapy, ocular imaging, artificial intelligence, and surgical innovation.

Moorfields’ long history, specialist focus, research partnership, education role, and international reputation support its position among established Centers of Excellence.

National Cancer Center Hospital Japan

• Headquarters: Tokyo, Japan
• Founded: 1962

National Cancer Center Hospital Japan is one of Asia’s most important oncology Centers of Excellence. As a national cancer institution, it plays a central role in cancer diagnosis, treatment, research, clinical trials, and policy-relevant oncology infrastructure in Japan.

The hospital’s strength lies in its focused cancer mission and its integration with national research and clinical development systems. It provides specialist care across solid tumors, hematologic malignancies, radiation therapy, surgical oncology, endoscopy, pathology, imaging, precision medicine, and clinical trials.

Its role within Japan’s healthcare system gives it importance beyond patient care alone. National cancer centers often help establish standards, support research networks, guide clinical development, and train specialists. This broader institutional function is central to the Center of Excellence model.

National Cancer Center Hospital Japan’s oncology specialization, national role, clinical expertise, and research integration support its inclusion among established Centers of Excellence.

Sheba Medical Center Heart Center

• Headquarters: Ramat Gan, Israel
• Founded: 1948

Sheba Medical Center Heart Center is a major cardiovascular Center of Excellence within one of the Middle East’s leading medical campuses. The center provides specialist care across cardiology, cardiac surgery, structural heart disease, electrophysiology, cardiac imaging, heart failure, and interventional procedures.

Its strength lies in combining a focused cardiovascular platform with the broader infrastructure of Sheba Medical Center. Complex cardiac care requires intensive care, imaging, rehabilitation, emergency support, advanced diagnostics, surgical teams, and long-term follow-up. Sheba’s campus structure supports this integrated care model.

The center also benefits from Sheba’s broader orientation toward medical innovation, international collaboration, and advanced clinical programs. This gives it regional relevance for patients seeking complex cardiovascular care in the Middle East and beyond.

Sheba Medical Center Heart Center’s cardiovascular specialization, regional referral role, multidisciplinary structure, and institutional innovation profile support its inclusion among established Centers of Excellence.

University Health Network Transplant and Cancer Platforms

• Headquarters: Toronto, Canada
• Founded: 1999

University Health Network in Toronto operates one of Canada’s most important academic health science platforms, with major strengths in transplantation, oncology, cardiovascular care, neuroscience, rehabilitation, and clinical research. Its Center of Excellence profile is especially strong through Toronto General Hospital and Princess Margaret Cancer Centre.

The transplant platform benefits from UHN’s clinical complexity and academic relationship with the University of Toronto. Transplant care requires highly coordinated multidisciplinary teams, specialized surgical expertise, immunology, critical care, infectious disease management, and long-term patient monitoring.

Princess Margaret Cancer Centre provides a complementary oncology Center of Excellence within the same institutional network, supporting cancer care, clinical trials, precision medicine, radiation oncology, hematologic malignancies, and translational research.

UHN’s ability to operate multiple specialist centers within a unified academic health science environment gives it significant institutional strength. Its combination of transplant leadership, oncology depth, research integration, and national healthcare relevance supports its inclusion among established Centers of Excellence.

---

Tier III — Specialist Centers of Excellence

(Alphabetical order)

Bascom Palmer Eye Institute

• Core focus: complex ophthalmology, eye research and specialist training

Bascom Palmer Eye Institute is an established healthcare institution whose principal relevance to this ranking lies in complex ophthalmology, eye research and specialist training. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Bascom Palmer Eye Institute contributes a credible combination of these characteristics.

Bascom Palmer Eye Institute is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Cincinnati Children’s Hospital Medical Center

Cincinnati Children’s Hospital Medical Center is an established healthcare institution whose principal relevance to this ranking lies in centers of excellence. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Cincinnati Children’s Hospital Medical Center contributes a credible combination of these characteristics.

Cincinnati Children’s Hospital Medical Center is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Cleveland Clinic Neurological Institute

• Core focus: integrated neurology, neurosurgery and neuroscience care

Cleveland Clinic Neurological Institute is an established healthcare institution whose principal relevance to this ranking lies in integrated neurology, neurosurgery and neuroscience care. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Cleveland Clinic Neurological Institute contributes a credible combination of these characteristics.

Cleveland Clinic Neurological Institute is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Duke Cancer Institute

• Core focus: multidisciplinary oncology, trials and translational cancer research

Duke Cancer Institute is an established healthcare institution whose principal relevance to this ranking lies in multidisciplinary oncology, trials and translational cancer research. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Duke Cancer Institute contributes a credible combination of these characteristics.

Duke Cancer Institute is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Karolinska Comprehensive Cancer Centre

Karolinska Comprehensive Cancer Centre is an established healthcare institution whose principal relevance to this ranking lies in centers of excellence. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Karolinska Comprehensive Cancer Centre contributes a credible combination of these characteristics.

Karolinska Comprehensive Cancer Centre is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

National Heart Centre Singapore

• Core focus: advanced cardiovascular care, research and regional referral services

National Heart Centre Singapore is an established healthcare institution whose principal relevance to this ranking lies in advanced cardiovascular care, research and regional referral services. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. National Heart Centre Singapore contributes a credible combination of these characteristics.

National Heart Centre Singapore is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

National Neuroscience Institute Singapore

• Core focus: neurology, neurosurgery and specialist neuroscience programs

National Neuroscience Institute Singapore is an established healthcare institution whose principal relevance to this ranking lies in neurology, neurosurgery and specialist neuroscience programs. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. National Neuroscience Institute Singapore contributes a credible combination of these characteristics.

National Neuroscience Institute Singapore is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Royal Brompton and Harefield Hospitals

• Core focus: complex heart and lung medicine, surgery and transplantation

Royal Brompton and Harefield Hospitals is an established healthcare institution whose principal relevance to this ranking lies in complex heart and lung medicine, surgery and transplantation. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Royal Brompton and Harefield Hospitals contributes a credible combination of these characteristics.

Royal Brompton and Harefield Hospitals is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Royal Marsden Hospital and Institute of Cancer Research

Royal Marsden Hospital and Institute of Cancer Research is an established healthcare institution whose principal relevance to this ranking lies in centers of excellence. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Royal Marsden Hospital and Institute of Cancer Research contributes a credible combination of these characteristics.

Royal Marsden Hospital and Institute of Cancer Research is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Shriners Children’s

• Core focus: specialized pediatric orthopaedics, burns and rehabilitation

Shriners Children’s is an established healthcare institution whose principal relevance to this ranking lies in specialized pediatric orthopaedics, burns and rehabilitation. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Shriners Children’s contributes a credible combination of these characteristics.

Shriners Children’s is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Singapore National Heart Centre

Singapore National Heart Centre is an established healthcare institution whose principal relevance to this ranking lies in centers of excellence. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Singapore National Heart Centre contributes a credible combination of these characteristics.

Singapore National Heart Centre is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Texas Children’s Hospital

Texas Children’s Hospital is an established healthcare institution whose principal relevance to this ranking lies in centers of excellence. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Texas Children’s Hospital contributes a credible combination of these characteristics.

Texas Children’s Hospital is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

UCSF Helen Diller Family Comprehensive Cancer Center

• Core focus: academic oncology, precision medicine and clinical trials

UCSF Helen Diller Family Comprehensive Cancer Center is an established healthcare institution whose principal relevance to this ranking lies in academic oncology, precision medicine and clinical trials. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. UCSF Helen Diller Family Comprehensive Cancer Center contributes a credible combination of these characteristics.

UCSF Helen Diller Family Comprehensive Cancer Center is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

UPMC Hillman Cancer Center

• Core focus: integrated cancer care, research and regional oncology delivery

UPMC Hillman Cancer Center is an established healthcare institution whose principal relevance to this ranking lies in integrated cancer care, research and regional oncology delivery. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. UPMC Hillman Cancer Center contributes a credible combination of these characteristics.

UPMC Hillman Cancer Center is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

Wills Eye Hospital

• Core focus: specialist ophthalmology, surgery, research and professional education

Wills Eye Hospital is an established healthcare institution whose principal relevance to this ranking lies in specialist ophthalmology, surgery, research and professional education. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in centers of Excellence.

Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Wills Eye Hospital contributes a credible combination of these characteristics.

Wills Eye Hospital is placed in Tier III because its category-specific capabilities are meaningful and commercially established, while its overall breadth, market influence, or international reach remains more focused than the institutions placed above it. The classification is intended as an editorial assessment of institutional position rather than a medical, investment, or procurement recommendation.

---

Remarks

Centers of Excellence continue to play a growing role in global healthcare as patients, payers, employers, and health systems seek trusted platforms for complex, high-risk, and highly specialized care. These institutions are increasingly important because they combine concentrated expertise with multidisciplinary coordination, research infrastructure, and structured patient pathways.

The institutions recognized in this ranking represent Centers of Excellence or equivalent specialist platforms whose clinical and academic capabilities maintain sustained relevance within advanced healthcare systems. Tier classification reflects relative institutional positioning within the Center of Excellence segment rather than direct clinical outcome rankings.

Tier classification reflects relative specialty depth, care coordination capability, research integration, referral influence, institutional reputation, and long-term platform resilience. The ranking does not constitute a medical recommendation, patient referral guidance, investment recommendation, or evaluation of individual physician performance.

---

Recognition

Inclusion in the Top 30 Centers of Excellence 2026 ranking is an editorial determination of The Economy Rankings and is independent of licensing, advertising, sponsorship, or other commercial participation.

Ranked organizations may factually refer to their inclusion in the ranking in their own communications. When describing the result, institutions should accurately reflect the tier structure and methodology used in the published ranking.

How the ranking should be interpreted

• Tier I represents the Top 5 institutions, and the published order within Tier I reflects the ranking order.
• Tier II represents institutions ranked within the Top 15, following Tier I. Institutions within Tier II are displayed alphabetically; their displayed order should therefore not be interpreted as an individual numerical ranking.
• Tier III represents institutions ranked within the Top 30, following Tiers I and II. Institutions within Tier III are also displayed alphabetically, and their displayed order should not be interpreted as an individual numerical ranking.
• An institution’s tier, rather than its alphabetical position within Tier II or Tier III, should therefore be used when describing its standing.

Referencing the ranking

Depending on the institution’s published tier, appropriate factual descriptions may include:

• Tier I: “Ranked Tier I” or “Ranked among the Top 5”
• Tier II: “Ranked Tier II” or “Ranked among the Top 15”
• Tier III: “Ranked Tier III” or “Ranked among the Top 30”

Organizations should not describe an alphabetical position within Tier II or Tier III as a specific numerical rank.

Use of The Economy Rankings recognition materials

Editorial inclusion in a ranking does NOT by itself grant permission to use The Economy Rankings badges, seals, logos, official recognition graphics, licensed quotations, or other proprietary recognition materials.

Organizations wishing to use official The Economy Rankings recognition materials in corporate websites, marketing materials, investor communications, patient or professional communications, presentations, social media, press releases, or other external communications should refer to the applicable licensing terms and usage policies:

• The Economy Rankings License Structure — available licence levels and permitted recognition uses
  Rankings License Structure | The Economy
• The Economy Rankings License Policy — licensing conditions governing use of The Economy Rankings recognition, marks, and related materials
  The Economy Rankings License Policy | The Economy
• Recognition Use Guide — guidance on permitted wording, presentation, attribution, and use of ranking recognition
  Recognition Use Guide | The Economy

Ranking inclusion remains editorially independent regardless of whether an organization purchases or holds a recognition-materials licence.

Licensing inquiries:
[email protected]